|
|
Post by compound26 on Dec 8, 2017 20:05:20 GMT -5
Thanks Sportsrancho for posting that. We're ironing out some kinks with the website, and creating a more robust platform by which to promote what we're doing. We've been busy and there's been very good feedback on the basic business and treatment model. Come here often and keep us posted.  We really want you guys to be immensely successful! |
|
|
|
Post by vdexdiabetes on Dec 8, 2017 20:09:13 GMT -5
thanks, will do. Maybe be a bit spotty, but we'll be back
|
|
|
|
Post by sportsrancho on Dec 9, 2017 12:26:02 GMT -5
You guys are the best of the best!!
|
|
|
|
Post by u1682002 on Dec 9, 2017 15:37:42 GMT -5
Hi Sports., never spent time to understand the VDEX model and how can they make profit. As far as you know, can they actually make any profit? Or making profit is just a secondary mission for them.
|
|
|
|
Post by sportsrancho on Dec 9, 2017 15:59:03 GMT -5
Hi Sports., never spent time to understand the VDEX model and how can they make profit. As far as you know, can they actually make any profit? Or making profit is just a secondary mission for them. As far as I know it’s confidential for competitive reasons. But I assume like any other business you work your butt off, put the patients first, and then reap rewards down the line:-) |
|
|
|
Post by sla55 on Dec 12, 2017 15:10:19 GMT -5
VDEX Diabetes on Facebook:
Nurse Practitioners
$55 / hour
Full-time
Hello,
We are looking for a Nurse Practitioner to hire for a clinical trial we are running in New Mexico. This will likely evolve into a full time position. We are an actively expanding company and looking to get into the New Mexico market.
A little about VDEX:
A VDEX treatment facility is a specialized medical practice that focuses on only one disease area: diabetes. Further, we specialize in one aspect of that disease: blood sugar control. The logic of this approach is simple: blood sugar control is more nuanced, more difficult. Yet, blood sugar control, or the lack thereof, leads to all the complications.
Vdex has one simple aim: To enable diabetics to live a normal or nearly normal life. A disease unlike most other medical conditions, diabetes is a chronic condition with devastating long-term consequences. It requires hour-by-hour attention to avoid equally devastating short-term consequences. Patients need regular care and monitoring for life. Through our "Real Time Diabetes Management" model, diabetics have far better control of blood glucose levels and reduced hypoglycemia as compared to the current, best therapies available today.
We at Vdex believe with the latest therapies and technological innovations, our patients can SAFELY maintain average HbA1c levels significantly below 6.5 and even 6.0. A significant number of patients using Vdex protocols actually have HbA1c levels BELOW 6.0, all with NO INCREASE IN HYPOGLYCEMIA.
Our Goal: Our goal is to get into the New Mexico market and work with nurse practitioners to get blood sugar under control in both Type 1 and Type 2 diabetics. We have a proven track record of not only getting great control but also maintaining great control for these diabetics to live as free as they can from diabetes. We do that with our protocols and use of Afrezza.
New West Ct
Santa Fe, NM 87506
|
|
|
|
Post by sportsrancho on Dec 12, 2017 15:29:39 GMT -5
:-)))
|
|
|
|
Post by galt1965 on Dec 12, 2017 16:15:04 GMT -5
Sla, Sports, and all the rest of you: Thank you all for your continuous hard work in getting all this information out there. I deeply appreciate it |
|
|
|
Post by peppy on Dec 12, 2017 16:18:27 GMT -5
I think this is brilliant. Get a referral from your family practice physician for vdex. |
|
|
|
Post by sportsrancho on Dec 13, 2017 8:29:51 GMT -5
|
|
|
|
Post by sportsrancho on Dec 27, 2017 19:36:00 GMT -5
|
|
|
|
Post by vdexdiabetes on Dec 28, 2017 13:11:25 GMT -5
At the risk of opening the kimono too much, let me say that Vdex is NOT set up as a charity or a vehicle to pump up the stock price of MNKD, but is very much a profit-making endeavor. We believe, in fact, we have proven, that our model will be quite profitable. That said, our first concern when we organized the company was an evaluation of Afrezza and the design of protocols to best use the product. We've learned a ton. Afrezza is every bit as good as Al Mann said it was, and actually a little better (I'll leave details on that point for a later post). We have played with different protocols and have developed our own after some trial and error. Suffice to say, we are highly confident about improving blood sugar control with virtually every diabetic. That's not to say we're so wonderful, but rather because Afrezza is. What Vdex contributes are protocols for the best way to use Afrezza.
It has been mentioned before but bears repeating, Afrezza is not the easiest product to use correctly. There is a learning curve. We know; we traveled it. But the effort is clearly worth it. There is simply no better way to manage blood sugar, in our opinion, than with Afrezza.
Like all new endeavors, Vdex has had its share of bumps. We have been resolute in our approach because its quite clear that something has to change in the treatment of diabetes. Our goal is to make that change happen. We are now at a point where we can begin our expansion in earnest. I don't want to set false expectations, but we do not intend to merely operate a few centers in Southern California. Our sights are set considerably higher. We know there will be challenges and that we will make mistakes. That's entrepreneurship. We don't fear that; we embrace it.
|
|
|
|
Post by sr71 on Dec 28, 2017 13:54:32 GMT -5
At the risk of opening the kimono too much, let me say that Vdex is NOT set up as a charity or a vehicle to pump up the stock price of MNKD, but is very much a profit-making endeavor. We believe, in fact, we have proven, that our model will be quite profitable. That said, our first concern when we organized the company was an evaluation of Afrezza and the design of protocols to best use the product. We've learned a ton. Afrezza is every bit as good as Al Mann said it was, and actually a little better (I'll leave details on that point for a later post). We have played with different protocols and have developed our own after some trial and error. Suffice to say, we are highly confident about improving blood sugar control with virtually every diabetic. That's not to say we're so wonderful, but rather because Afrezza is. What Vdex contributes are protocols for the best way to use Afrezza. It has been mentioned before but bears repeating, Afrezza is not the easiest product to use correctly. There is a learning curve. We know; we traveled it. But the effort is clearly worth it. There is simply no better way to manage blood sugar, in our opinion, than with Afrezza. Like all new endeavors, Vdex has had its share of bumps. We have been resolute in our approach because its quite clear that something has to change in the treatment of diabetes. Our goal is to make that change happen. We are now at a point where we can begin our expansion in earnest. I don't want to set false expectations, but we do not intend to merely operate a few centers in Southern California. Our sights are set considerably higher. We know there will be challenges and that we will make mistakes. That's entrepreneurship. We don't fear that; we embrace it. Very well-spoken. Over time, the success of people with diabetes using Afrezza will make many companies successful, starting with VDEX and Mannkind. |
|
|
|
Post by hellodolly on Dec 28, 2017 14:05:53 GMT -5
At the risk of opening the kimono too much, let me say that Vdex is NOT set up as a charity or a vehicle to pump up the stock price of MNKD, but is very much a profit-making endeavor. We believe, in fact, we have proven, that our model will be quite profitable. That said, our first concern when we organized the company was an evaluation of Afrezza and the design of protocols to best use the product. We've learned a ton. Afrezza is every bit as good as Al Mann said it was, and actually a little better (I'll leave details on that point for a later post). We have played with different protocols and have developed our own after some trial and error. Suffice to say, we are highly confident about improving blood sugar control with virtually every diabetic. That's not to say we're so wonderful, but rather because Afrezza is. What Vdex contributes are protocols for the best way to use Afrezza. It has been mentioned before but bears repeating, Afrezza is not the easiest product to use correctly. There is a learning curve. We know; we traveled it. But the effort is clearly worth it. There is simply no better way to manage blood sugar, in our opinion, than with Afrezza. Like all new endeavors, Vdex has had its share of bumps. We have been resolute in our approach because its quite clear that something has to change in the treatment of diabetes. Our goal is to make that change happen. We are now at a point where we can begin our expansion in earnest. I don't want to set false expectations, but we do not intend to merely operate a few centers in Southern California. Our sights are set considerably higher. We know there will be challenges and that we will make mistakes. That's entrepreneurship. We don't fear that; we embrace it. Thank you so much for recognizing the contributions and efforts of so many people, like al Mann and those researchers and scientists that have put their scientific reputation and life into making this happen. Although you don't have the intention of supporting the SP by pumping this miracle drug, the long term benefit to PWDs and the demand for the drug will eventually support the fair value of MNKD stock in the end. " Afrezza is every bit as good as Al Mann said it was, and actually a little better" says volumes to me as a shareholder. Best regards. |
|
|
|
Post by dreamboatcruise on Dec 28, 2017 15:45:05 GMT -5
At the risk of opening the kimono too much, let me say that Vdex is NOT set up as a charity or a vehicle to pump up the stock price of MNKD, but is very much a profit-making endeavor. We believe, in fact, we have proven, that our model will be quite profitable. That said, our first concern when we organized the company was an evaluation of Afrezza and the design of protocols to best use the product. We've learned a ton. Afrezza is every bit as good as Al Mann said it was, and actually a little better (I'll leave details on that point for a later post). We have played with different protocols and have developed our own after some trial and error. Suffice to say, we are highly confident about improving blood sugar control with virtually every diabetic. That's not to say we're so wonderful, but rather because Afrezza is. What Vdex contributes are protocols for the best way to use Afrezza. It has been mentioned before but bears repeating, Afrezza is not the easiest product to use correctly. There is a learning curve. We know; we traveled it. But the effort is clearly worth it. There is simply no better way to manage blood sugar, in our opinion, than with Afrezza. Like all new endeavors, Vdex has had its share of bumps. We have been resolute in our approach because its quite clear that something has to change in the treatment of diabetes. Our goal is to make that change happen. We are now at a point where we can begin our expansion in earnest. I don't want to set false expectations, but we do not intend to merely operate a few centers in Southern California. Our sights are set considerably higher. We know there will be challenges dand that we will make mistakes. That's entrepreneurship. We don't fear that; we embrace it. Have you been collecting statistics on your clinical population (A1c, time in range)? Will it be used in marketing? or published? |
|
We really want you guys to be immensely successful!
